BICKI-IL-7

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBICKI-IL-7

Drug Alias NameBICKI-IL-7

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-PD-1Interleukin-7 receptor subunit alpha inhibitors

TargetsProgrammed cell death protein 1Interleukin-7 receptor subunit alpha

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOse Immunotherapeutics

China Registration ClassN/A

Develop Information

Active CompaniesOse Immunotherapeutics

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A